US Stock MarketDetailed Quotes

EYEN Eyenovia

Watchlist
  • 0.771
  • -0.033-4.14%
Close May 10 16:00 ET
  • 0.789
  • +0.018+2.27%
Post 17:31 ET
39.30MMarket Cap-1168P/E (TTM)

About Eyenovia Company

Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.

Company Profile

SymbolEYEN
Company NameEyenovia
Listing DateJan 25, 2018
Issue Price10.00
Founded2014
CEOMr. Michael M. Rowe
MarketNASDAQ
Employees57
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address295 Madison Avenue,Suite 2400
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10017
Phone1-833-393-6684
Websitehttp://www.eyenovia.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael M. Rowe
  • Chief Executive Officer and Director
  • 775.47K
  • John P. Gandolfo
  • Principal Accounting Officer, Chief Financial Officer and Secretary
  • 685.45K
  • Bren Kern
  • Chief Operating Officer
  • 566.99K
  • Dr. Tsontcho Ianchulev, M.D.
  • Executive Chairman of the Board
  • 247.50K
  • Michael S. Geltzeiler
  • Independent Director
  • 57.83K
  • Rachel Jacobson
  • Independent Director
  • 145.00K
  • Ellen R. Strahlman, M.D.
  • Independent Director
  • 162.50K
  • Dr. Ram Palanki
  • Independent Director
  • 140.00K
  • Charles E. Mather, IV
  • Independent Director
  • 148.75K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg